Drug Shortage Report for DEXAMETHASONE SODIUM PHOSPHATE INJ USP 4MG/ML
Report ID | 131386 |
Drug Identification Number | 00664227 |
Brand name | DEXAMETHASONE SODIUM PHOSPHATE INJ USP 4MG/ML |
Common or Proper name | DEXAMETHASONE SODIUM PHOSPHATE INJ USP 4MG/ML |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | DEXAMETHASONE PHOSPHATE |
Strength(s) | 4MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR INTRASYNOVIAL INTRAVENOUS INTRAMUSCULAR INTRASYNOVIAL INTRAVENOUS |
Packaging size | 5ML 10LIVI CA |
ATC code | H02AB |
ATC description | CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2021-01-08 |
Estimated end date | 2021-02-05 |
Actual end date | 2021-01-22 |
Shortage status | Resolved |
Updated date | 2021-01-25 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2021-01-25 | French | Compare |
v5 | 2021-01-25 | English | Compare |
v4 | 2021-01-15 | French | Compare |
v3 | 2021-01-15 | English | Compare |
v2 | 2021-01-12 | French | Compare |
v1 | 2021-01-12 | English | Compare |
Showing 1 to 6 of 6